Telomir Pharmaceuticals Files 8-K with Corporate Details
Ticker: TELO · Form: 8-K · Filed: Jul 17, 2025 · CIK: 1971532
Sentiment: neutral
Topics: corporate-filing, address-update
Related Tickers: TELO
TL;DR
Telomir Pharma (TELO) filed an 8-K on 7/17/25, updating its Miami HQ address.
AI Summary
On July 17, 2025, Telomir Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is located at 100 SE 2nd St, Suite 2000 #1009, Miami, Florida, 33131, and its principal executive offices are also at this address. The company's telephone number is (786) 396-6723.
Why It Matters
This filing provides essential corporate information and addresses for Telomir Pharmaceuticals, Inc., which is important for investors and stakeholders to know where the company is officially located and how to contact them.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not contain information that inherently increases or decreases risk.
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- 100 SE 2nd St, Suite 2000 #1009, Miami, Florida, 33131 (location) — Principal Executive Offices
- July 17, 2025 (date) — Date of Report
- (786) 396-6723 (phone_number) — Business Phone
FAQ
What is the exact name of the company filing this report?
The exact name of the registrant is Telomir Pharmaceuticals, Inc.
On what date was this 8-K report filed or effective?
The report was filed as of July 17, 2025.
Where are Telomir Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices are located at 100 SE 2nd St, Suite 2000 #1009, Miami, Florida.
What is the business phone number for Telomir Pharmaceuticals, Inc.?
The business phone number is (786) 396-6723.
In which state was Telomir Pharmaceuticals, Inc. incorporated?
The company was incorporated in Florida.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding Telomir Pharmaceuticals, Inc. (TELO).